Wolverine Trading
INFI

Wolverine Trading’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Wolverine Trading’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-23,700
Closed -$13K – 5189
2022
Q4 		$13K Sell
23,700
-1,000
-4% -$851 ﹤0.01% 3801
2022
Q3 		$29K Buy
+24,700
New +$26.6K ﹤0.01% 4305
2022
Q2 		– Sell
-19,100
Closed -$22K – 6061
2022
Q1 		$22K Sell
19,100
-34,200
-64% -$40.9K ﹤0.01% 5238
2021
Q4 		$125K Buy
+53,300
New +$134K ﹤0.01% 4988
2021
Q3 		– Sell
-35,400
Closed -$110K – 7219
2021
Q2 		$110K Buy
35,400
+6,400
+22% +$20.2K ﹤0.01% 5363
2021
Q1 		$88K Buy
29,000
+10,400
+56% +$34.7K ﹤0.01% 5484
2020
Q4 		$41K Buy
+18,600
New +$30.7K ﹤0.01% 4641
2019
Q1 		– Sell
-29,500
Closed -$35K – 5531
2018
Q4 		$35K Buy
29,500
+7,900
+37% +$14.2K ﹤0.01% 4222
2018
Q3 		$59K Sell
21,600
-4,600
-18% -$9.52K ﹤0.01% 4673
2018
Q2 		$55K Hold
26,200
– – ﹤0.01% 4886
2018
Q1 		$55K Sell
26,200
-5,700
-18% -$12.2K ﹤0.01% 4886
2017
Q4 		$65K Buy
+31,900
New +$66.2K ﹤0.01% 4560
2017
Q3 		– Sell
-24,500
Closed -$40K – 5231
2017
Q2 		$40K Buy
24,500
+10,100
+70% +$19.5K ﹤0.01% 4095
2017
Q1 		$48K Buy
+14,400
New +$35.4K ﹤0.01% 4009
2016
Q4 		– Sell
-12,300
Closed -$19K – 5347
2016
Q3 		$19K Buy
+12,300
New +$18.9K ﹤0.01% 4509

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wolverine Trading's INFI Position: Q4 2022 in Review

Wolverine Trading sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2022, closing a stake of 11,895 shares — an estimated $10.1K sold.

Wolverine Trading first reported a position in INFI in Q2 2016 and held it in 10 quarters. The position peaked at $112K in Q1 2021. 68 funds tracked by Wall St. Rank hold INFI as of Q4 2022.

  • Wolverine Trading reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Wolverine Trading sold 11,895 Infinity Pharmaceuticals, Inc. shares in Q4 2022, an estimated $10.1K.
  • Wolverine Trading first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2016 and held it in 10 quarters.
  • Wolverine Trading's Infinity Pharmaceuticals, Inc. position peaked at $112K in Q1 2021.
  • 68 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.